SCHEMBL21383576

SCHEMBL21383576

COC(=O)c1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.58
PGR P06401 1/20 0.58
NR3C2 P08235 1/20 0.58
AR P10275 1/20 0.58
HDAC3 O15379 1/20 0.57
HDAC4 P56524 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC7 Q8WUI4 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC10 Q969S8 1/20 0.57
HDAC11 Q96DB2 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
HDAC9 Q9UKV0 1/20 0.57
HDAC5 Q9UQL6 1/20 0.57
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.56
KMT2A Q03164 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17912674 0.88 NR4A2 (0.54) NR3C1PGRNR3C2ARHDAC3
SCHEMBL21383594 0.85 HDAC3 (0.50) NR3C1PGRNR3C2ARHDAC3
SCHEMBL28885915 0.85 NR4A2 (0.50) NR3C1PGRNR3C2ARMEN1
SCHEMBL21383578 0.83 NR4A2 (0.58) GUSBNR4A2MGAMGAASI
SCHEMBL21399536 0.83 NR4A2 (0.58) TDP1GUSBNR4A2MGAMGAA
SCHEMBL21399703 0.83 HDAC3 (0.59) NR3C1PGRNR3C2ARHDAC3
SCHEMBL21399535 0.82 NR4A2 (0.59) GUSBNR4A2MGAMGAASI
SCHEMBL7298601 0.82 GUSB (0.48) GUSBMGAMGAASIMGAM2
SCHEMBL21399537 0.82 MAP2K4 (0.52) MEN1MAPTKMT2AGUSBRAB9A
SCHEMBL28501875 0.82 RAB9A (0.47) NR3C1PGRNR3C2ARMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024499-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF XIAMEN UNIVERSITY (CN) 2021-01-28 US disclosed
WO-2019183527-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2019-09-26 WO disclosed
WO-2019183527-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2019-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024499-A1 OXIDIZED BIS(3-INDOLYL)METHANES AND USES THEREOF BCL2, BCOR, BCLAF1 NR3C1 71/4885PGR 893/4885NR3C2 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.